Neurologic manifestations of Chagas disease (Q37929640)

25 August 2017

1 reference

title

Neurologic manifestations of Chagas disease (English)

1 reference

25 August 2017

0 references

Marco Oliveira Py

1

1 reference

25 August 2017

1 December 2011

1 reference

Current Neurology and Neuroscience Reports

25 August 2017

1 reference

25 August 2017

11

1 reference

25 August 2017

536-542

1 reference

25 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-011-0225-8

25 August 2017

0 references

cites work

Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Clinical and epidemiological aspects of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Chagas disease in Spain, the United States and other non-endemic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Chagas disease and blood transfusion: an emerging issue in non-endemic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Clinical reasoning: a 35-year-old man with a right hemiplegia and a cerebral mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Late reactivation of Chagas' disease presenting in a recipient as an expansive mass lesion in the brain after heart transplantation of chagasic myocardiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Neurological manifestations of Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

[Exercise testing and 24 hours Holter monitoring in the detection of complex ventricular arrhythmias in different stages of chronic Chagas' heart disease].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Neurological manifestations in Chagas disease without cardiac dysfunction: correlation between dysfunction of the parasympathetic nervous system and white matter lesions in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Parasympathetic nervous system dysfunction and neurological consequences of chagas disease. Mediator or bystander?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

The presence of antiautonomic membrane receptor antibodies do not correlate with brain lesions in Chagas' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Involvement of the central nervous system in the chronic form of Chagas' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Chagas disease is independently associated with brain atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

A population-based study of the association between Trypanosoma cruzi infection and cognitive impairment in old age (the Bambuí Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Ischemic cerebral changes in the chronic chagasic cardiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

American trypanosomiasis (Chagas' disease): an unrecognised cause of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Chagas disease is an independent risk factor for stroke: baseline characteristics of a Chagas Disease cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Chagas disease: independent risk factor for stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Stroke history and Chagas disease are independent predictors of silent cerebral microembolism in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Prevention strategies of cardioembolic ischemic stroke in Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

An Estimate of the Burden of Chagas Disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

21 January 2018

12 December 2020

Chagas Disease Predicts 10-Year Stroke Mortality in Community-Dwelling Elderly

1 reference

https://api.crossref.org/works/10.1007%2FS11910-011-0225-8

[Embolic cerebral vascular accidents in chronic Chagas' heart disease]

21 January 2018

1 reference

12 December 2020

[Neurological effects of American trypanosomyiasis: clinical aspects].

1 reference

12 December 2020

Autonomic dysfunction in Chagas disease: lack of participation of the vagus nerve

1 reference

12 December 2020

Cognitive impairment in human chronic Chagas' disease.

1 reference

12 December 2020

Stroke in asymptomatic Trypanosoma cruzi-infected patients

1 reference

12 December 2020

Control of Chagas disease

1 reference

12 December 2020

Successful thrombolysis in cardioembolic stroke from Chagas disease

1 reference

12 December 2020

Peripheral nervous system involvement in human and experimental chronic American trypanosomiasis

1 reference

12 December 2020

1 reference

12 December 2020

Chagas' disease and the involvement of the autonomic nervous system

1 reference

12 December 2020

Central nervous system involvement in Chagas' disease. An updating.

1 reference

12 December 2020

Chagas disease predicts 10-year stroke mortality in community-dwelling elderly: the Bambui cohort study of aging

1 reference

12 December 2020

10.1007/S11910-011-0225-8

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21904918